Plaques and Ulcers of Both Lower Limbs: A Quiz
DOI:
https://doi.org/10.2340/actadv.v105.42510Keywords:
Necrobiotic Xanthogranuloma, cholesterol crystals, tofacitinibDownloads
References
Wood AJ, Wagner MVU, Abbott JJ, Gibson LE. Necrobiotic Xanthogranuloma: A review of 17 cases with emphasis on clinical and pathologic correlation. Arch Dermatol 2009; 145: 279-284.
https://doi.org/10.1001/archdermatol.2008.583 DOI: https://doi.org/10.1001/archdermatol.2008.583
Fernández-Herrera J, Pedraz J. Necrobiotic xanthogranuloma. Semin Cutan Med Surg. 2007; 26: 108-113.
https://doi.org/10.1016/j.sder.2007.02.008 DOI: https://doi.org/10.1016/j.sder.2007.02.008
Nelson CA, Zhong CS, Hashemi DA, Ashchyan HJ, Brown-Joel Z, Noe MH, et al. A multicenter cross-sectional study and systematic review of necrobiotic xanthogranuloma with proposed diagnostic criteria. JAMA Dermatol 2020; 156: 270-279.
https://doi.org/10.1001/jamadermatol.2019.4221 DOI: https://doi.org/10.1001/jamadermatol.2019.4221
Steinhelfer L, Kühnel T, Jägle H, Mayer S, Karrer S, Haubner F, et al. Systemic therapy of necrobiotic xanthogranuloma: a systematic review. Orphanet J Rare Dis 2022; 17: 132.
https://doi.org/10.1186/s13023-022-02291-z DOI: https://doi.org/10.1186/s13023-022-02291-z
Sood S, Heung M, Georgakopoulos JR, Mufti A, Prajapati VH, Yeung J. Use of Janus kinase inhibitors for granulomatous dermatoses: A systematic review. J Am Acad Dermatol 2023; 89: 357-359.
https://doi.org/10.1016/j.jaad.2023.03.024 DOI: https://doi.org/10.1016/j.jaad.2023.03.024
Bijlsma WR, Van Den Bosch WA, Van Daele PLA, Paridaens D. Azathioprine and prednisone combination treatment for adult periocular and orbital xanthogranulomatous disease. Acta Ophthalmol (Copenh) 2011; 89: 278-282.
https://doi.org/10.1111/j.1755-3768.2009.01726.x DOI: https://doi.org/10.1111/j.1755-3768.2009.01726.x
Shahriari N. Intravenous immunoglobulin-refractory necrobiotic xanthogranuloma successfully treated with tofacitinib 2% cream. JAAD Case Rep 2022; 32: 41-43.
https://doi.org/10.1016/j.jdcr.2022.12.002 DOI: https://doi.org/10.1016/j.jdcr.2022.12.002
Miguel D, Lukacs J, Illing T, Elsner P. Treatment of necrobiotic xanthogranuloma - a systematic review. J Eur Acad Dermatol Venereol 2017; 31: 221-235.
https://doi.org/10.1111/jdv.13786 DOI: https://doi.org/10.1111/jdv.13786
Szalat R, Pirault J, Fermand J ‐P., Carrié A, Saint‐Charles F, Olivier M, et al. Physiopathology of necrobiotic xanthogranuloma with monoclonal gammopathy. J Intern Med 2014; 276: 269-284.
https://doi.org/10.1111/joim.12195 DOI: https://doi.org/10.1111/joim.12195
Geoloaica LG, Patrascu V, Ciurea RN. Necrobiotic xanthogranuloma - case report and literature review. Curr Health Sci J 2021; 47: 126-131.
Published
How to Cite
License
Copyright (c) 2025 Qianling Zhang, Sha Lu, Xiqing Li, Liangchun Wang, Jianchi Ma

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.